perfosfamide has been researched along with Local Neoplasm Recurrence in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambinder, RF; Blackford, AL; Davis-Sproul, JM; Gocke, CD; Gore, SD; Jones, RJ; Kasamon, YL; Seifter, EJ | 1 |
Haake, R; Kersey, JH; Ramsay, NK; Uckun, FM; Weisdorf, D | 1 |
Altomonte, V; Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM | 1 |
Jones, RJ; Miller, CB; Piantadosi, S; Rowley, SD; Zehnbauer, BA | 1 |
Bloom, EJ; Borochovitz, D; Colvin, OM; Gonzales-Chambers, R; Mangan, KF; Przepiorka, D; Rosenfeld, CS; Shadduck, RK | 1 |
1 review(s) available for perfosfamide and Local Neoplasm Recurrence
Article | Year |
---|---|
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Female; Follow-Up Studies; Granulocytes; Humans; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stem Cells; Survival Rate; Whole-Body Irradiation | 1991 |
1 trial(s) available for perfosfamide and Local Neoplasm Recurrence
Article | Year |
---|---|
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Follow-Up Studies; Humans; Leukemia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2011 |
3 other study(ies) available for perfosfamide and Local Neoplasm Recurrence
Article | Year |
---|---|
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone ma
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Burkitt Lymphoma; CD24 Antigen; Complement System Proteins; Cyclophosphamide; Cytarabine; Flow Cytometry; Fluorescent Antibody Technique; Humans; Membrane Glycoproteins; Neoplasm Recurrence, Local; Neprilysin; Rabbits; Remission Induction; Tetraspanin 29; Transplantation, Autologous; Tumor Stem Cell Assay; Whole-Body Irradiation | 1992 |
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Skin; Skin Diseases | 1992 |
Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclophosphamide; Drug Resistance; Female; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Stem Cell Assay | 1991 |